Bolus Mitomycin C and 5-FU with Sequential Radiation for Poor-Prognosis Locally Advanced Cervical Cancer

Author： denehy T.R.   Eastman R.   SanFilippo L.   Gregori C.A.   Breen J.L.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.60, Iss.1, 1996-01, pp. : 64-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary

By Assersohn L.   Norman A.R.   Cunningham D.   Iveson T.   Seymour M.   Hickish T.   Massey A.   Prior Y.   Hill M.E.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1121-1128

Elsevier

Access to resources Recommend Favorite

A Randomized Trial of Standard versus Partially Hyperfractionated Radiation with or without Concurrent 5-Fluorouracil in Locally Advanced Cervical Cancer

By Thomas G.   Dembo A.   Ackerman I.   Franssen E.   Balogh J.   Fyles A.   Levin W.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 137-145

Elsevier

Access to resources Recommend Favorite

Carboplatin as a Radiation Sensitizer in Locally Advanced Cervical Cancer: A Pilot Study

By Muderspach L.I.   Curtin J.P.   Roman L.D.   Gebhardt J.A.   Klement V.   Qian D.   Morrow C.P.   Felix J.C.   Formenti S.C.   Muggia F.M.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 336-342

Elsevier

Access to resources Recommend Favorite

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups

By Bosset J.F.   Roelofsen F.   Morgan D.A.L.   Budach V.   Coucke P.   Jager J.J.   Van der Steen-Banasik E.   Triviere N.   Stuben G.   Puyraveau M.   Mercier M.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

By Benavides M.   García-Alfonso P.   Cobo M.   Muñoz-Martín A.   Gil-Calle S.   Carabantes F.   Villar E.   Graupera J.   Balcells M.   Pérez-Manga G.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 255-262

Humana Press, Inc

Access to resources Recommend Favorite